Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?

Abstract Background There is an urgent need to identify effective therapy to treat coronavirus diseases 2019 (COVID-19). Supplement consumption is becoming popular in this pandemic era. An example of this is probiotic consumption to improve the host's immune system. Objective This study a...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Surgean Veterini, Anna, Cita Rosita Sigit Prakoeswa, -, Damayanti Tinduh, -, Satuman, -
Format: Article PeerReviewed
Language:English
Indonesian
English
English
Indonesian
Published: Elsevier
Subjects:
Online Access:https://repository.unair.ac.id/128399/1/1.Simple%20Neutralization.pdf
https://repository.unair.ac.id/128399/2/Karil%201.pdf
https://repository.unair.ac.id/128399/3/1%20Turnitin.pdf
https://repository.unair.ac.id/128399/4/1.%20Korespondensi.pdf
https://repository.unair.ac.id/128399/5/1.%20Etik_.pdf
https://repository.unair.ac.id/128399/
https://www.sciencedirect.com/science/article/pii/S2405580822001480?via%3Dihub
https://doi.org/10.1016/j.bbrep.2022.101348
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
Indonesian
English
English
Indonesian
id id-langga.128399
record_format dspace
spelling id-langga.1283992023-10-23T00:09:09Z https://repository.unair.ac.id/128399/ Simple neutralization test report: Do probiotics contribute to COVID-19 therapy? Anna Surgean Veterini, Anna Cita Rosita Sigit Prakoeswa, - Damayanti Tinduh, - Satuman, - R5-920 Medicine (General) Abstract Background There is an urgent need to identify effective therapy to treat coronavirus diseases 2019 (COVID-19). Supplement consumption is becoming popular in this pandemic era. An example of this is probiotic consumption to improve the host's immune system. Objective This study aimed to prove whether antibodies from people taking probiotics could influence lactate dehydrogenase (LDH), adenosine triphosphate (ATP) values, and cell viability in vitro in peripheral blood mononuclear cells (PBMCs) inoculated with the SARS-CoV-2 spike protein as COVID-19 cells models. Methods This was an experimental study with control and intervention groups, totally in 12 groups divided based on antibody levels, probiotic intervention, probiotic non-intervention group, SARS-CoV-2 infection group, and non-SARS-CoV-2 infection group. In vitro assays were carried out on PBMC cell cultures inoculated with S1 SARS-CoV-2 recombinant as a COVID-19 cell model. The COVID-19 cell model was given antibodies divided into three antibody level groups: sRBD levels of <3, 325.76 and 646.18. The cytotoxicity assessment examined increased levels of LDH, cytopathic activity by measuring ATP levels, and cell viability by XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) assay. Data were analyzed with SPSS 21 for Windows. Results This study showed a significant difference in the LDH value (p < 0.001) between each group. The difference in ATP values between groups was significant (p < 0.001). Meanwhile, the cell viability examination found that there was a tendency of decreased XTT (cell viability in %) when there was an increase of LDH and ATP. Conclusion The change of LDH values occurred most in the antibody group that did not consume probiotics. The highest cytopathic activity based on the ATP values occurred in the infected cell culture group with antibody levels of 325.76 and consuming probiotics. In addition, LDH and ATP activities provided evidence of a significant influence on cell viability. Elsevier Article PeerReviewed text en https://repository.unair.ac.id/128399/1/1.Simple%20Neutralization.pdf text id https://repository.unair.ac.id/128399/2/Karil%201.pdf text en https://repository.unair.ac.id/128399/3/1%20Turnitin.pdf text en https://repository.unair.ac.id/128399/4/1.%20Korespondensi.pdf text id https://repository.unair.ac.id/128399/5/1.%20Etik_.pdf Anna Surgean Veterini, Anna and Cita Rosita Sigit Prakoeswa, - and Damayanti Tinduh, - and Satuman, - Simple neutralization test report: Do probiotics contribute to COVID-19 therapy? Biochemistry and Biophysics Reports (BBR), 32. ISSN 2405-5808 https://www.sciencedirect.com/science/article/pii/S2405580822001480?via%3Dihub https://doi.org/10.1016/j.bbrep.2022.101348
institution Universitas Airlangga
building Universitas Airlangga Library
continent Asia
country Indonesia
Indonesia
content_provider Universitas Airlangga Library
collection UNAIR Repository
language English
Indonesian
English
English
Indonesian
topic R5-920 Medicine (General)
spellingShingle R5-920 Medicine (General)
Anna Surgean Veterini, Anna
Cita Rosita Sigit Prakoeswa, -
Damayanti Tinduh, -
Satuman, -
Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
description Abstract Background There is an urgent need to identify effective therapy to treat coronavirus diseases 2019 (COVID-19). Supplement consumption is becoming popular in this pandemic era. An example of this is probiotic consumption to improve the host's immune system. Objective This study aimed to prove whether antibodies from people taking probiotics could influence lactate dehydrogenase (LDH), adenosine triphosphate (ATP) values, and cell viability in vitro in peripheral blood mononuclear cells (PBMCs) inoculated with the SARS-CoV-2 spike protein as COVID-19 cells models. Methods This was an experimental study with control and intervention groups, totally in 12 groups divided based on antibody levels, probiotic intervention, probiotic non-intervention group, SARS-CoV-2 infection group, and non-SARS-CoV-2 infection group. In vitro assays were carried out on PBMC cell cultures inoculated with S1 SARS-CoV-2 recombinant as a COVID-19 cell model. The COVID-19 cell model was given antibodies divided into three antibody level groups: sRBD levels of <3, 325.76 and 646.18. The cytotoxicity assessment examined increased levels of LDH, cytopathic activity by measuring ATP levels, and cell viability by XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) assay. Data were analyzed with SPSS 21 for Windows. Results This study showed a significant difference in the LDH value (p < 0.001) between each group. The difference in ATP values between groups was significant (p < 0.001). Meanwhile, the cell viability examination found that there was a tendency of decreased XTT (cell viability in %) when there was an increase of LDH and ATP. Conclusion The change of LDH values occurred most in the antibody group that did not consume probiotics. The highest cytopathic activity based on the ATP values occurred in the infected cell culture group with antibody levels of 325.76 and consuming probiotics. In addition, LDH and ATP activities provided evidence of a significant influence on cell viability.
format Article
PeerReviewed
author Anna Surgean Veterini, Anna
Cita Rosita Sigit Prakoeswa, -
Damayanti Tinduh, -
Satuman, -
author_facet Anna Surgean Veterini, Anna
Cita Rosita Sigit Prakoeswa, -
Damayanti Tinduh, -
Satuman, -
author_sort Anna Surgean Veterini, Anna
title Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_short Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_full Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_fullStr Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_full_unstemmed Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?
title_sort simple neutralization test report: do probiotics contribute to covid-19 therapy?
publisher Elsevier
url https://repository.unair.ac.id/128399/1/1.Simple%20Neutralization.pdf
https://repository.unair.ac.id/128399/2/Karil%201.pdf
https://repository.unair.ac.id/128399/3/1%20Turnitin.pdf
https://repository.unair.ac.id/128399/4/1.%20Korespondensi.pdf
https://repository.unair.ac.id/128399/5/1.%20Etik_.pdf
https://repository.unair.ac.id/128399/
https://www.sciencedirect.com/science/article/pii/S2405580822001480?via%3Dihub
https://doi.org/10.1016/j.bbrep.2022.101348
_version_ 1781413383957905408